{
}
The global retinal laser photocoagulation market is projected to exceed USD 349.25 million by 2031, driven by the increasing prevalence of ocular diseases and a growing geriatric population. Key players include Alcon, Ellex Medical, and Carl Zeiss, with advancements in laser technology enhancing treatment precision. However, challenges such as infection risks and stringent regulations may hinder market growth.
Alcon Inc. (ALC), a leader in eye care products, is positioned for growth with a Zacks Rank of #3 (Hold) and a Growth Style Score of B. Projected earnings and sales are set to rise by 10.6% and 4.8% year-over-year, respectively, with cash flow expected to grow by 16.5% this year. With solid fundamentals and upward revisions in earnings estimates, ALC is a stock to watch for investors seeking long-term growth.
Needham & Company has named Alcon (NYSE: ALC) its top pick for 2025, raising the price target to $108 and adding the stock to its Conviction List. The firm anticipates significant revenue growth from eight upcoming product launches, particularly the PanOptix Pro, which is expected to enhance earnings and margins.Analysts project robust performance in cataracts and contact lenses, with strong demand for intraocular lenses and a positive outlook for the Unity VCS launch. Valuation remains attractive, with a P/E ratio of 25.7x, indicating potential for multiple expansion as earnings outlook strengthens.
Needham & Company has named Alcon as its top pick for 2025, raising the price target to $108 and adding it to its Conviction List. The firm anticipates significant revenue growth from eight upcoming product launches, particularly the PanOptix Pro, which is expected to enhance margins and earnings by 2026. Analysts project robust performance in cataracts and contact lenses, with a favorable valuation at a P/E ratio of 25.7x, indicating a 14% discount to its historical average.
Needham & Company has named Alcon (NYSE: ALC) its top pick for 2025, adding the stock to its Conviction List and raising the price target to $108. The firm anticipates significant revenue growth from eight upcoming product launches, particularly the PanOptix Pro, which is expected to enhance earnings and margins.Analysts project robust performance in cataracts and contact lenses, with strong demand for intraocular lenses and a positive outlook for the Unity VCS launch. Alcon's stock is currently trading at a P/E ratio of 25.7x, presenting an attractive valuation compared to its historical average.
Needham has upgraded Alcon Inc.'s price target from $103 to $108, maintaining a Buy rating and naming it a top pick for 2025 due to strong margin and earnings growth prospects. The firm highlights promising upcoming product launches and a solid financial position, with Alcon reporting a 6% sales increase and a 25% rise in core EPS in Q3 2024. Alcon's strategic initiatives and partnerships, alongside a commitment to innovation, position the company well for future growth.
Needham has upgraded Alcon Inc.'s price target from $103 to $108, maintaining a Buy rating and naming it a top pick for 2025 due to strong margin and earnings growth prospects. The firm highlights promising product launches and a solid financial position, with a recent 6% sales increase and a 25% rise in core EPS. Alcon aims for mid-20s operating margins by 2027, supported by strategic partnerships and ongoing innovation.
Alcon stock remains a compelling choice for investors, driven by strong fundamentals and growth potential in the eye care market. The company's innovative product pipeline and strategic initiatives position it well for future success, making it a valuable addition to investment portfolios.
Alcon Inc (ALC) has entered oversold territory with a Relative Strength Index (RSI) of 29.1, indicating potential exhaustion of recent selling pressure. The stock traded as low as $84.03, well below its 52-week high of $101.10, prompting bullish investors to consider buying opportunities.
Alcon Inc. (VTX:ALC) carries a net debt of approximately $2.70 billion, with total liabilities of $5.22 billion exceeding its cash and near-term receivables. Despite this, the company has a strong market capitalization of $42.6 billion and demonstrates solid financial health, with an interest cover of 8.3 times and a 29% increase in EBIT over the past year, indicating manageable debt levels and the ability to generate free cash flow.
Alcon Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global retinal laser photocoagulation market poised for significant growth by 2031
United States Dollar
Quantel Medical SAS
CARL ZEISS MEDITEC
Alcon Inc.
FRA
KOR
GBR
ESP
USA
DEU
ITA
CAN
CHN
IND
BRA
ARG
ZAF
JPN
MEX
Navilash Thirunahari
Show more
08:20 24.12.2024
Alcon emerges as a promising growth stock for investors to consider
15:45 23.12.2024
Alcon named top pick for 2025 with strong product launch outlook
15:48 17.12.2024
Alcon named top pick for 2025 with strong product launch outlook
15:48 17.12.2024
Alcon named top pick for 2025 with strong product launch outlook
15:48 17.12.2024
Alcon named top stock pick for 2025 with strong growth prospects
12:44 17.12.2024
Needham names Alcon top pick for 2025 amid strong growth prospects
12:43 17.12.2024
reasons to keep alcon stock in your investment portfolio
00:23 14.12.2024
Alcon shares enter oversold territory signaling potential buying opportunity
18:54 13.12.2024
Alcon's Debt Management: Balancing Risk and Return in Medical Equipment Sector
13:49 12.12.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Supply Chain Management
Stock Market Updates
Private Equity Deals
Government Economic Policies
Industry Mergers & Acquisitions
Fintech Startups
Energy Sector Developments
AI Applications
Funding Rounds & Investments
Venture Capital Investments
AI Innovations
Emerging Startups
Commodities
CEO Changes
Inflation and Monetary Impact
Countries:
Companies:
Apple Inc.
Google Inc.
Tesmec S.p.A.
Amazon.com, Inc.
Microsoft Corporation
Mastercard Inc
NVIDIA Corp
Tesla, Inc.
OpenAI ERC USD
The Goldman Sachs Group, Inc.
Visa Inc.
SWIGGY LIMITED
GLOE Inc.
Mistral 1
S&P 500
Ripple USD USD
NAURA Technology Group Co., Ltd.
OLA ELECTRIC MOBILITY LTD
Microsoft Corp
Micron Technology, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
United Arab Emirates Dirham
British Pound Sterling
Saudi Riyal
New Zealand Dollar
Qatari Riyal
Thai Baht
Vietnamese Đồng
Canadian Dollar
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Brazilian Real
Swiss Franc
Bangladeshi Taka
Kuwaiti Dinar
People: